The authors demonstrated this with 3 mouse models mentioned above (Cd2ap-KO, Lamb2-KO, and Adriamycin) and 3 examples of human nephrotic disease (minimal change disease, FSGS, and diabetic nephropathy). This evidence concerns the gene CD2AP and lipoid nephrosis.